[Retracted] The Role of Jinhuang Powder to Prevent Adverse Effects of Subcutaneous Injection of Enoxaparin Sodium

Table 1

Basic information of patients.

	Research group (n = 58)	Control group (n = 39)
Age (years)	60.2 ± 9.5	56.2 ± 10.7	0.056
BMI	23.19 ± 3.49	22.46 ± 3.67	0.328
Diabetes (n)
Yes	9	0	0.010
No	49	39
Hypertension (n)
Yes	20	14	0.886
No	38	25
ECO score (n)	1 (0–3)	1 (0–3)	0.224
Concurrent chemotherapy (n)
Yes	38	35	0.007
No	20	4
Platelet count (10/L)	239 ± 103	227 ± 119	0.600
Dimer (ng/ml)	1144.2 ± 1004.8	1070.7 ± 859.3	0.709
PT (s)	12.6 ± 1.2	12.8 ± 0.7	0.359
APTT(s)	29.1 ± 2.9	29.7 ± 3.7	0.342